119 related articles for article (PubMed ID: 37536036)
21. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
22. Identification of a Primary Renal AT
Kemp BA; Howell NL; Gildea JJ; Keller SR; Carey RM
Circ Res; 2020 Feb; 126(5):644-659. PubMed ID: 31997705
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan.
Nakamura T; Yamamoto E; Kataoka K; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
Hypertension; 2008 Feb; 51(2):296-301. PubMed ID: 18158350
[TBL] [Abstract][Full Text] [Related]
24. Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
Tanabe A; Naruse M; Hara Y; Sato A; Tsuchiya K; Nishikawa T; Imaki T; Takano K
J Hypertens; 2004 May; 22(5):1017-23. PubMed ID: 15097243
[TBL] [Abstract][Full Text] [Related]
25. Chronic administration of pharmacological doses of angiotensin 1-7 and iodoangiotensin 1-7 has minimal effects on blood pressure, heart rate, and cognitive function of spontaneously hypertensive rats.
Stoyell-Conti FF; Chabbra A; Puthentharayil J; Rigatto K; Speth RC
Physiol Rep; 2021 Apr; 9(7):e14812. PubMed ID: 33904655
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension.
Alhusban A; Kozak A; Pillai B; Ahmed H; Sayed MA; Johnson MH; Ishrat T; Ergul A; Fagan SC
PLoS One; 2017; 12(6):e0178867. PubMed ID: 28640888
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats.
Duke LM; Paull JR; Widdop RE
Clin Exp Pharmacol Physiol; 2003; 30(5-6):317-23. PubMed ID: 12859420
[TBL] [Abstract][Full Text] [Related]
28. Metoprolol restores expression and vasodilatation function of AT2R in spontaneously hypertensive rats.
Li Y; Li XH; Huang ZJ; Tang XH; Liu JJ; Yuan H
J Cardiovasc Pharmacol; 2014 Mar; 63(3):252-8. PubMed ID: 24193197
[TBL] [Abstract][Full Text] [Related]
29. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA
J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney.
Pandey A; Goru SK; Kadakol A; Malek V; Gaikwad AB
Biochimie; 2015 Nov; 118():71-81. PubMed ID: 26271886
[TBL] [Abstract][Full Text] [Related]
31. Intrarenal aminopeptidase N inhibition restores defective angiontesin II type 2-mediated natriuresis in spontaneously hypertensive rats.
Padia SH; Howell NL; Kemp BA; Fournie-Zaluski MC; Roques BP; Carey RM
Hypertension; 2010 Feb; 55(2):474-80. PubMed ID: 19996063
[TBL] [Abstract][Full Text] [Related]
32. Activation of angiotensin type 2 receptor attenuates testosterone-induced hypertension and uterine vascular resistance in pregnant rats†.
Mishra JS; Kumar S
Biol Reprod; 2021 Jul; 105(1):192-203. PubMed ID: 33739377
[TBL] [Abstract][Full Text] [Related]
33. Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function?
Cediel E; Sanz-Rosa D; Oubina MP; de las Heras N; González Pacheco FR; Vegazo O; Jiménez J; Cachofeiro V; Lahera V
Am J Physiol Regul Integr Comp Physiol; 2003 Sep; 285(3):R674-81. PubMed ID: 12775556
[TBL] [Abstract][Full Text] [Related]
34. Role of the angiotensin AT(1) receptor in rat aortic and cardiac PAI-1 gene expression.
Chen HC; Bouchie JL; Perez AS; Clermont AC; Izumo S; Hampe J; Feener EP
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2297-302. PubMed ID: 11031218
[TBL] [Abstract][Full Text] [Related]
35. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
Harada N; Shimozawa N; Okajima K
Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
[TBL] [Abstract][Full Text] [Related]
36. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
38. Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
Javkhedkar AA; Lokhandwala MF; Banday AA
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F47-51. PubMed ID: 21900450
[TBL] [Abstract][Full Text] [Related]
39. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
Banday AA; Lokhandwala MF
Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
[TBL] [Abstract][Full Text] [Related]
40. Chronic NF-κB blockade improves renal angiotensin II type 1 receptor functions and reduces blood pressure in Zucker diabetic rats.
Luo H; Wang X; Wang J; Chen C; Wang N; Xu Z; Chen S; Zeng C
Cardiovasc Diabetol; 2015 Jun; 14():76. PubMed ID: 26055622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
